About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Annals of Hepatology
›
top-articles
Annals of Hepatology
2.2
(top 20%)
impact factor
3.4K
(top 5%)
papers
40.3K
(top 10%)
citations
68
(top 10%)
h
-index
2.4
(top 20%)
impact factor
4.1K
all documents
42.7K
doc citations
97
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Bile Acid Physiology
Annals of Hepatology
2017
306
2
Prevalence of non-alcoholic fatty liver disease: population based study
Annals of Hepatology
2007
293
3
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
Annals of Hepatology
2013
252
4
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Annals of Hepatology
2009
244
5
The Role of the Gut Microbiota in Bile Acid Metabolism
Annals of Hepatology
2017
210
6
Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women. The role of estrogens
Annals of Hepatology
2010
192
7
AST to platelet ratio index (APRI) for the noninvasive evaluation of liver fibrosis
Annals of Hepatology
2008
187
8
Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances in Reverse Cholesterol Transport
Annals of Hepatology
2017
172
9
Impact of untreated portal vein thrombosis on pre and post liver transplant outcomes in cirrhosis
Annals of Hepatology
2013
167
10
The importance of redox state in liver damage
Annals of Hepatology
2004
158
11
Pentoxifylline for the treatment of non-alcoholic steatohepatitis: a randomized controlled trial
Annals of Hepatology
2011
153
12
S-adenosylmethionine metabolism and liver disease
Annals of Hepatology
2013
152
13
Prevalence of non-alcoholic fatty liver disease: population based study
Annals of Hepatology
2007
145
14
Management Strategies for Liver Fibrosis
Annals of Hepatology
2017
144
15
Metabolic syndrome and non-alcoholic fatty liver disease
Annals of Hepatology
2009
143
16
Liver fibrosis and inflammation. A review
Annals of Hepatology
2003
141
17
What is changing in indications and treatment of hepatic hemangiomas. A review
Annals of Hepatology
2014
137
18
The role of zinc in liver cirrhosis
Annals of Hepatology
2016
137
19
Gut microbiota and nonalcoholic fatty liver disease
Annals of Hepatology
2012
136
20
Biliary secretion and excretion in health and disease: Current concepts
Annals of Hepatology
2007
127
21
Hepatocellular carcinoma. An overview
Annals of Hepatology
2006
125
22
New Insights About Albumin and Liver Disease
Annals of Hepatology
2018
125
23
The Role of Bile Acids in Glucose Metabolism and Their Relation with Diabetes
Annals of Hepatology
2017
123
24
The prevalence of nonalcoholic fatty liver disease in the Americas
Annals of Hepatology
2014
122
25
Hepatic encephalopathy, ammonia, glutamate, glutamine and oxidative stress
Annals of Hepatology
2009
119
26
Anti-cancer effects of blue-green alga Spirulina platensis, a natural source of bilirubin-like tetrapyrrolic compounds
Annals of Hepatology
2014
118
27
NASH and cryptogenic cirrhosis: A histological analysis
Annals of Hepatology
2009
117
28
Dipeptidyl peptidase IV (DDP IV) in NASH patients
Annals of Hepatology
2007
115
29
Cholestasis: human disease and experimental animal models
Annals of Hepatology
2003
113
30
Treatment of nonalcoholic steatohepatitis with probiotics. A proof-of-concept study
Annals of Hepatology
2013
111
31
Epidemiology and natural history of non-alcoholic fatty liver disease (NAFLD)
Annals of Hepatology
2009
110
32
Kava hepatotoxicity. A clinical review
Annals of Hepatology
2010
104
33
Post-liver transplantation medical complications
Annals of Hepatology
2006
103
34
Prevalence of hepatitis B and C seropositivity in a Nigerian cohort of HIV-infected patients
Annals of Hepatology
2008
99
35
Epidemiology of hepatocellular carcinoma in sub-Saharan Africa
Annals of Hepatology
2013
96
36
Metformin is effective in achieving biochemical response in patients with nonalcoholic fatty liver disease (NAFLD) not responding to lifestyle interventions
Annals of Hepatology
2007
95
37
Advanced hepatocellular carcinoma. Review of targeted molecular drugs
Annals of Hepatology
2011
94
38
Imaging techniques for assessing hepatic fat content in nonalcoholic fatty liver disease
Annals of Hepatology
2008
91
39
Early allograft dysfunction after liver transplantation: an intermediate outcome measure for targeted improvements
Annals of Hepatology
2016
89
40
Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
Annals of Hepatology
2017
89
41
Reversibility of liver fibrosis
Annals of Hepatology
2009
88
42
Brain edema in acute liver failure. A window to the pathogenesis of hepatic encephalopathy
Annals of Hepatology
2003
86
43
Liver disease during pregnancy: acute viral hepatitis
Annals of Hepatology
2006
86
44
Trends in liver disease prevalence in Mexico from 2005 to 2050 through mortality data
Annals of Hepatology
2005
84
45
Severe hepatotoxicity by Indian Ayurvedic herbal products: A structured causality assessment
Annals of Hepatology
2009
84
46
Hepatogenous diabetes. Current views of an ancient problem
Annals of Hepatology
2009
84
47
Association between butyrylcholinesterase activity and low-grade systemic inflammation
Annals of Hepatology
2012
84
48
Kupffer cells: increasingly significant role in nonalcoholic fatty liver disease
Annals of Hepatology
2014
84
49
Association of plasma visfatin with hepatic and systemic inflammation in nonalcoholic fatty liver disease
Annals of Hepatology
2013
83
50
Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis
Annals of Hepatology
2017
83
site/software ©
exaly
; All materials licenced under
CC by-SA
.